Article
CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer.
Medical oncology (Northwood, London, England) - 26 Dec 2022
Song YingQiu, Sun Kai, Gong LiLan, Shi LinLi, Qin Tao, Wang ShuSen, Deng WuGuo, Chen WangBing, Zheng FeiMeng, Li GuiLing
Abstract excerpt
Lung cancer is the leading cause of malignant tumor-related deaths worldwide. The presence of tumor-initiating cells in lung cancer leads to tumor recurrence, metastasis, and resistance to conventional treatment. Cleavage and polyadenylation specificity factor 4 (CPSF4) activation in tumor cells contributes to the poor prognosis of lung cancer. However, the precise biological functions and molecular mechanisms of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
